MedicalSystem Biotechnology (SHE:300439) won an equity dispute case after a court ordered a shareholder to pay 143,976 yuan to the company, according to a Shenzhen Stock Exchange disclosure on Saturday.
Yao Danhua, a shareholder of the company's wholly-owned subsidiary Hangzhou Yitian Biotechnology, was ordered to pay the amount due to failure to perform obligations in an equity transfer deal.
The case was filed in 2021 at the Ningbo Intermediate People's Court of China's Zhejiang Province, the in vitro diagnostic product manufacturer said.
The company's shares rose 1% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.